RHY ASX Chart
Snapshot
Rhythm Biosciences Limited (RHY) is developing and commercializing Australian medical diagnostics technology for sale in domestic and international markets. Its ColoSTAT product in development aims to provide an accurate and early detection test for colorectal cancer.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2024 YTD | |
1 Year | |
vs Sector (1yr) | -63.65% |
vs ASX 200 (1yr) | -65.22% |
Announcements
Corporate Overview
Corporate Details
Head Office | Parkville VIC 3010 |
Website | www.rhythmbio.com |
Registry | Automic Group |
Auditor | BDO Audit Pty Ltd |
Date Listed | 7 Dec 2017 |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
27/02/2025 | Report (Interim) |
29/08/2025 | Report (Prelim) |
29/08/2025 | Report (Annual) |
25/09/2025 | Report (Annual) |
Former Company Names
- RHYTHM Biosciences Ltd has no former company names.
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
RHY directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of RHY directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
Michelle Wing | 15/08/2024 | 18,117,500 | 7.29 |
Otto Buttula | 15/08/2024 | 36,384,575 | 14.64 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
Date | Name | Bought | Previous % | New % |
---|---|---|---|---|
21-03-24 | Otto Buttula | 10,850,000 | 11.10 | 14.21 |
12-12-23 | Daniel Eddington and Julie Eddington | 11,765,052 | -- | 5.30 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
Date | Name | Sold | Previous % | New % |
---|---|---|---|---|
21-03-24 | FIL Limited and the entities | 11,097,492 | 5.02 | -- |
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2024 | $0.062 | 28 June |
2023 | $0.41 | 30 June |
2022 | $1.15 | 30 June |
2021 | $0.885 | 30 June |
2020 | $0.079 | 30 June |
2019 | $0.18 | 28 June |
2018 | $0.205 | 29 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.